OnSite takes on Hypertension's CVProfiler:
This article was originally published in Clinica
Health services provider OnSite Wellness Medical Associates is to add Hypertension Diagnostics' CVProfiler, used for the early detection of cardiovascular disease, to its range of tests. St Paul, Minnesota-based Hypertension stresses that, while the disease is usually associated with the middle-aged and elderly, it is the second largest cause of death in the US of those aged 25-64 years and is the third largest cause of death in the 15-24 year-old age group.
You may also be interested in...
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.